These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2324520)

  • 1. Site-specific suppression of cell-mediated immunity by cyclosporine.
    Black KS; Nguyen DK; Proctor CM; Patel MP; Hewitt CW
    J Invest Dermatol; 1990 May; 94(5):644-8. PubMed ID: 2324520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
    Towpik E; Kupiec-Weglinski JW; Schneider TM; Tyler D; Padberg W; Araneda D; Tilney NL
    Transplantation; 1985 Dec; 40(6):714-8. PubMed ID: 3907046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of a 10-year experience on methods and compositions for inducing site-specific immunosuppression with topical immunosuppressants.
    Hewitt CW; Black KS
    Transplant Proc; 1996 Apr; 28(2):922-3. PubMed ID: 8623464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rat skin allograft rejection by cyclosporine. In situ characterization of the impaired local immune response.
    Guillén FJ; Hancock WW; Towpik E; Kupiec-Weglinski JW; Rickles FR; Tilney NL; Murphy GF
    Transplantation; 1986 Jun; 41(6):734-9. PubMed ID: 3520989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of skin allografts in rats treated with topical cyclosporine.
    Lai CS; Wesseler TA; Alexander JW; Babcock GF
    Transplantation; 1987 Jul; 44(1):83-7. PubMed ID: 3299925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prolongation of skin allograft survival by topical use of cyclosporine A.
    Zhao XF; Schroeder TJ; Alexander JW; Miskell P; Gonce SJ; Babcock GF
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):670-3. PubMed ID: 3284116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of accelerated rejection of cardiac allografts in sensitized rats by anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy.
    Kupiec-Weglinski JW; Sablinski T; Hancock WW; Di Stefano R; Mariani G; Mix CT; Tilney NL
    Transplantation; 1991 Feb; 51(2):300-5. PubMed ID: 1825240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
    Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
    J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The survival and nature of the immune response to soft-tissue and composite-tissue allografts in rats treated with low-dose cyclosporine.
    Sobrado L; Pollak R; Robichaux WH; Martin PC; Sullivan KA; Swartz WM
    Transplantation; 1990 Sep; 50(3):381-5. PubMed ID: 2402786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic effect of low-dose cyclosporine and fluocinolone acetonide on the survival of rat allogeneic skin grafts.
    Zhao XF; Alexander JW; Schroeder T; Babcock GF
    Transplantation; 1988 Oct; 46(4):490-2. PubMed ID: 3051553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The synergistic effect of low-dose cyclosporine and fluocinolone acetonide on the survival of rat allogenic skin graft].
    Zhao XF
    Zhonghua Wai Ke Za Zhi; 1989 Aug; 27(8):495-7, 510. PubMed ID: 2620608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine and skin allografts for the treatment of thermal injury. I. Extensive graft survival with low-level long-term administration and prolongation in a rat burn model.
    Hewitt CW; Black KS; Aguinaldo AM; Achauer BM; Howard EB
    Transplantation; 1988 Jan; 45(1):8-12. PubMed ID: 3276067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporine.
    Gassel HJ; Otto C; Gassel AM; Meyer D; Steger U; Timmermann W; Ulrichs K; Thiede A
    Transplantation; 2000 Mar; 69(6):1058-67. PubMed ID: 10762208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressive action of suppressor cells from antigen-cyclosporine-treated hosts on renal allograft survival.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Oct; 40(4):384-9. PubMed ID: 2413593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific immunosuppression: mechanisms of cellular immunosuppression that are operative at local and systemic levels.
    Patam MA; Tran HS; Llull R; Chrzanowski FA; Black KS; Hewitt CW
    J Burn Care Rehabil; 2000; 21(1 Pt 1):10-9. PubMed ID: 10661533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that cyclosporine does not inhibit allograft rejection by IL-2-treated sensitized splenocytes.
    Kemeny MM; Stephens DA
    Transplantation; 1987 Apr; 43(4):560-3. PubMed ID: 3554645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine and experimental skin allografts: long-term survival in rats treated with low maintenance doses.
    Towpik E; Kupiec-Weglinski JW; Tyler DS; Araujo JL; Schneider TM; Araneda D; Murphy GM; Tilney NL
    Plast Reconstr Surg; 1986 Feb; 77(2):268-76. PubMed ID: 3511482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model.
    Smith CR; Mohanakumar T; Shimizu Y; Yu S; Otomo N; Kaleem Z; Flye MW
    Transplantation; 2000 Jan; 69(2):294-9. PubMed ID: 10670641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
    Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess AD
    Transplantation; 1995 Jul; 60(2):115-22. PubMed ID: 7624952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.